Fellow Nurses Africa | Lagos, Nigeria | 14 October, 2025

In a groundbreaking moment for global health, researchers from the University of KwaZulu-Natal (UKZN) and the Africa Health Research Institute (AHRI) have announced promising results from Africa’s first HIV cure trial.
The study, presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI), has given renewed hope to millions living with HIV worldwide.
According to the research team, some participants in the trial were able to control the HIV virus without daily medication, remaining healthy for over a year after stopping antiretroviral therapy (ART).
The South African trial involved 20 women living with HIV who had started treatment early after infection. They received a combination of broadly neutralizing antibodies special proteins that attack multiple strains of the virus and an immune-boosting medication designed to help the body recognize and suppress HIV on its own.
Remarkably, six women managed to stay off medication for almost a year while maintaining undetectable viral loads. Four of them have now reached over 18 months of drug-free viral control.
While not a complete cure, scientists describe this as a “functional remission” a condition where the virus is under control without daily treatment.
Lead researchers at UKZN emphasize that the results are preliminary but deeply encouraging.
“This is a major step forward for Africa and the world,” said a member of the research team. “It shows that a cure—or long-term remission—might one day be possible right here on African soil.”
The study also marks a milestone in representation: it’s one of the first HIV cure trials globally conducted exclusively among African women, a group historically underrepresented in HIV research.
What This Means for People Living With HIV
Health experts are urging people not to stop taking their HIV medication. Current antiretroviral therapy remains the only proven way to keep the virus under control and prevent transmission.
However, this breakthrough signals that the world is closer than ever to finding a sustainable cure or remission strategy. Researchers are already planning larger trials to test the treatment in different populations.
Beyond science, this discovery carries a powerful message:
Hope is alive. Science is working. And Africa is rising at the forefront of innovation.
To everyone living with HIV, your journey matters, and progress is happening. With continued research, compassion, and global collaboration, a world without HIV may no longer be a distant dream.
Fellow Nurses Africa is the independent voice of African Nurses. We educate, inform and support the nursing profession.

Kehinde Oluwatosin is one of the many editors here at Fellow Nurses Africa and fellownurses.com.
He is a registered nurse with a Master of Science degree in healthcare leadership from the University of Hull, United Kingdom. Kehinde is passionate about advancing the nursing profession across Africa. As Co-Founder of Fellow Nurses Africa, he plays a key role in shaping editorial direction, ensuring our content educates, informs, and empowers nurses continent-wide.
With expertise in leadership, patient flow, and healthcare operations, Kehinde brings valuable insights to nursing news, career development, and policy discussions. He is committed to amplifying the voice of African nurses and driving positive change in the profession.









